We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 33 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. スペラファーマ Osaka//others
  4. 4 null/null
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター
  2. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  3. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成

medicine Product List

151～165 item / All 593 items

Displayed results
[Research Material] The Global Market for ALK-Positive Lung Cancer Treatment

[Research Material] The Global Market for ALK-Positive Lung Cancer Treatment

Global Market for ALK Positive Lung Cancer Treatment: Crizotinib, Alectinib, Ceritinib, Brigatinib, Others, Hospitals, Clinics, Others

This research report (Global ALK Positive Lung Cancer Treatment Market) investigates and analyzes the current state and outlook for the global market for ALK-positive lung cancer treatment over the next five years. It includes information on the overview of the global ALK-positive lung cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ALK-positive lung cancer treatment market include crizotinib, alectinib, ceritinib, brigatinib, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for ALK-positive lung cancer treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in ALK-positive lung cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Bone and Mineral Metabolism Disorder Treatment

[Research Material] Global Market for Bone and Mineral Metabolism Disorder Treatment

Global Market for Treatment of Bone and Mineral Metabolism Disorders: Bisphosphonates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal Binders, Metal...

This research report (Global Bone and Mineral Metabolism Disorders Treat) investigates and analyzes the current state and outlook for the global market for bone and mineral metabolism disorder treatments over the next five years. It includes information on the overview of the global bone and mineral metabolism disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the bone and mineral metabolism disorder treatment market by type include bisphosphonates, estrogens, phosphate binders, non-calcium, non-metal binders, metal binders, magnesium binders, vitamin D analogs and supplements, calcium mimetics, and calcium-magnesium supplements. The segments by application target hospital pharmacies, retail pharmacies, online pharmacies, and drugstores. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for bone and mineral metabolism disorder treatments.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments

[Research Material] Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments

Global Market for Vascular Occlusion Crisis Associated with Sickle Cell Disease Treatments: SGD-2083, Crizanlizumab, PF-04447943, NVX-50 ...

This research report (Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease) investigates and analyzes the current state and outlook for the global market of vaso-occlusive crises associated with sickle cell disease treatments over the next five years. It includes information on the overview of the global market for vaso-occlusive crises associated with sickle cell disease treatments, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for vaso-occlusive crises associated with sickle cell disease treatments include SGD-2083, crizanlizumab, PF-04447943, NVX-508, and others, while the segments by application include clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for vaso-occlusive crises associated with sickle cell disease treatments. The report also includes the market share of major companies in the vaso-occlusive crises associated with sickle cell disease treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Hematology Treatments

[Research Material] Global Market for Rare Hematology Treatments

Global Market for Rare Hematology Treatments: Plasma-Derived Factors, Recombinant Factors, Hemophilia A, Hemophilia B, von Willebrand Disease, Others

This research report (Global Rare Hematology Treatment Market) investigates and analyzes the current state and outlook for the global market of rare hematology treatments over the next five years. It includes information on the overview of the global rare hematology treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare hematology treatment market focus on plasma-derived factors and recombinant factors, while the segments by application target hemophilia A, hemophilia B, von Willebrand disease, and others. The regional segments calculate the market size for rare hematology treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare hematology treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

World Market for Treatment of Acquired Cystic Kidney Disease: Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Others, Hospitals, Clinics, Research Institutions, Others

This research report (Global Acquired Cystic Kidney Disease Treatment Dr) investigates and analyzes the current status and outlook for the global market of acquired cystic kidney disease treatment drugs over the next five years. It includes information on the overview of the global acquired cystic kidney disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antibiotics, non-steroidal anti-inflammatory drugs, and others, while the segments by application focus on hospitals, clinics, research institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acquired cystic kidney disease treatment drugs. It also includes the market share of major companies in the acquired cystic kidney disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Solar Keratosis

[Research Material] The Global Market for Treatment of Solar Keratosis

World Market for the Treatment of Sunlight (Solar) Keratosis: 854-A, ACT-01, AD-17137, Celecoxib, DFD-08, GDC-695 ...

This research report (Global Actinic (Solar) Keratosis Treatment Market) investigates and analyzes the current status and outlook for the global market for solar keratosis treatment over the next five years. It includes information on the overview of the global solar keratosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the solar keratosis treatment market include 854-A, ACT-01, AD-17137, celecoxib, DFD-08, GDC-695, and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for solar keratosis treatment. It also includes the market share of major companies in solar keratosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Sleep Paralysis Treatment

[Research Material] The Global Market for Sleep Paralysis Treatment

Global Market for Sleep Paralysis Treatment: Stimulants, Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants, Sodium Oxybate, Disease ...

This research report (Global Sleep Paralysis Treatment Market) investigates and analyzes the current state and outlook for the global market for sleep paralysis treatment over the next five years. It includes information on the overview of the global sleep paralysis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include stimulants, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and sodium oxybate, while the segments by application focus on hospitals, home care, care centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for sleep paralysis treatment. It also includes the market share of major companies in sleep paralysis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Lung and Airway Disease Treatment

[Research Material] Global Market for Lung and Airway Disease Treatment

Global Market for Lung and Airway Disease Treatment: Bronchodilators, Cytotoxic Drugs, Antibiotics, Others, Hospitals, Clinics, Others

This research report (Global Lung Pulmonary Airway Disease Treatment Mar) investigates and analyzes the current state and outlook for the global market for lung and airway disease treatment over the next five years. It includes information on the overview of the global lung and airway disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include bronchodilators, cytotoxic drugs, antibiotics, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for lung and airway disease treatment. It also includes the market share of major companies in lung and airway disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Esophageal Cancer Treatment Drugs

[Research Material] Global Market for Esophageal Cancer Treatment Drugs

Global Market for Esophageal Cancer Treatment Drugs: Fluorouracil, Cisplatin, Docetaxel, Carboplatin, Others, Targeted Therapy, Chemotherapy

This research report (Global Esophageal Cancer Drugs Market) investigates and analyzes the current status and outlook for the global market of esophageal cancer treatment drugs over the next five years. It includes information on the overview of the global esophageal cancer treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the esophageal cancer treatment drugs market include fluorouracil, cisplatin, docetaxel, carboplatin, and others, while the segments by application focus on targeted therapy and chemotherapy. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for esophageal cancer treatment drugs. It also includes the market share of major companies in esophageal cancer treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Pulmonary Fibrosis Treatment Drugs

[Research Material] Global Market for Pulmonary Fibrosis Treatment Drugs

Global Market for Pulmonary Fibrosis Treatments: Pirfenidone, Nintedanib, Hospitals, Clinics

This research report (Global Pulmonary Fibrosis Drug Market) investigates and analyzes the current status and outlook for the global market for pulmonary fibrosis treatment drugs over the next five years. It includes information on the overview of the global pulmonary fibrosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on pirfenidone and nintedanib, while the segments by application target hospitals and clinics. The regional segments calculate the market size for pulmonary fibrosis treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the pulmonary fibrosis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for the Treatment of Psoriasis

[Research Material] The Global Market for the Treatment of Psoriasis

World Market for Psoriasis Treatment: Topical Therapy, Phototherapy, Systemic Drugs, Biological Therapy, Hospitals, Clinics, Others

This research report (Global Plaque Psoriasis Treatment Market) investigates and analyzes the current state and outlook for the global market for the treatment of psoriasis over the next five years. It includes information on the overview of the global psoriasis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the psoriasis treatment market focus on topical therapies, phototherapy, systemic drugs, and biological therapies, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for psoriasis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in psoriasis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment Drugs for Resistant Pseudomonas Aeruginosa Infections

[Research Material] Global Market for Treatment Drugs for Resistant Pseudomonas Aeruginosa Infections

Global Market for Treatments of Pseudomonas aeruginosa Infections: Semi-synthetic Penicillins, Cephalosporins, Lactam Drugs, Others, Hospitals, Clinics, Home Care

This research report (Global Resistant Pseudomonas Aeruginosa Infections) investigates and analyzes the current status and outlook for the global market of treatments for resistant Pseudomonas aeruginosa infections over the next five years. It includes information on the overview of the global market for treatments of resistant Pseudomonas aeruginosa infections, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include semi-synthetic penicillins, cephalosporins, lactam drugs, and others, while the segments by application focus on hospitals, clinics, and home care. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for treatments of resistant Pseudomonas aeruginosa infections. It also includes the market share of major companies in the resistant Pseudomonas aeruginosa infection treatment market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Rheumatoid Arthritis Treatment

[Research Material] The Global Market for Rheumatoid Arthritis Treatment

Global Market for Rheumatoid Arthritis Treatment: Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing Spondylitis, Others, Retail Pharmacies, Online Pharmacies, Hospitals

This research report (Global Rheumatology Therapeutics Market) investigates and analyzes the current state and outlook for the global market for rheumatology treatments over the next five years. It includes information on the overview of the global rheumatology treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rheumatology treatment market include rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis, and others, while the segments by application focus on retail pharmacies, online pharmacies, and hospitals. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for rheumatology treatments. It also includes the market share of major companies in rheumatology treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Sickle Cell Disease Treatment

[Research Material] The Global Market for Sickle Cell Disease Treatment

Global Market for Sickle Cell Disease Treatment: Sickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin C Disease, Hospitals, Clinics, Others

This research report (Global Sickle Cell Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for sickle cell disease treatment over the next five years. It includes information on the overview of the global sickle cell disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include sickle cell anemia, sickle beta-thalassemia, and sickle hemoglobin C disease, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for sickle cell disease treatment. It also includes the market share of major companies in sickle cell disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Osteoporosis Treatment

[Research Material] The Global Market for Osteoporosis Treatment

Global Market for Osteoporosis Treatment: Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Receptor Modulators ...

This research report (Global Osteoporosis Treatment Market) investigates and analyzes the current status and outlook for the global osteoporosis treatment market over the next five years. It includes information on the overview of the global osteoporosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments by type in the osteoporosis treatment market focus on bisphosphonates, parathyroid hormone therapy, calcitonin, and selective estrogen receptor modulators (SERMs), while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for osteoporosis treatment. It also includes the market share of major companies in osteoporosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.